• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.75
  • VXN 19.84
  • VXO 16.03
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
Refresh      
LLY (Eli Lilly and Company)
Last Trade 117.98 Dividend/Share 2.58 PE Ratio 21.22
Date May 22-2019 Dividend Yield 2.187 Return on Assets 15.53
Change 1.4 ExDividend Date 2019-05-16 Return on Capital null
Bid null Latest EPS 3.13 Price/Sale 4.726
Ask null LatestEPS Date 2018-12-31 Price to Book 45.63
Volume null EPS ttm 5.560 Institutional % null
Avg Volume 5.14M Shares Outstanding 970.83M Insider % null
Open 116.58 Float 966.67M Short Ratio 3.170
Prev Close 116.58 Return On Equity 76.23 5 Year Change % 1.246
High 118.39 Consensus EPS 1.35 2 Year Change % 0.588
Low 116.12 No. of Estimate 1.000 1 Year Change % 0.458
52 Week High 132.13 EPS Surprise $ null YTD Change % 0.038
52 Week Low 81.61 EPS Surprise Percent 0 6 Month Change % 0.057
52 Week Change 46.615 EBITDA 0M 3 Month Change % -0.042
50 Day MA 121.17187 Revenue 0M 1 Month Change % 0.010
200 Day MA Gross Profit 0M 5 Day Change % 0.011
Market Cap 114538.63M Cash 0M 30 Day Change % -0.067
Beta 0.264849 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 26966991
Short Date 2019-04-15 Revenue Per Employee 0 Short Ratio 3.170
Data courtesy of IEX
Company Profile

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance; depression and diabetic peripheral neuropathic pain; attention-deficit hyperactivity disorder in children, adolescents, and adults; depression, bulimia nervosa, and obsessive-compulsive disorders; and bipolar depression and treatment-resistant depression. The company?s endocrinology products are used for diabetes; type 2 diabetes; osteoporosis in postmenopausal women; osteoporosis in postmenopausal women and men at high risk for fracture; and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers; and colorectal cancers, as well as offers cardiovascular products for treating erectile dysfunction, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and for the treatment of adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives; antibiotics used to treat respiratory diseases and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents for use in poultry; antibiotics used to control enteric infections in calves and swine; parasiticides for use on cattle and premises; and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products principally through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.